Cervical Cancer

Standard of Care Underused for Advanced Cervical Cancer

Standard of Care Underused for Advanced Cervical Cancer

Despite improved overall survival with standard of care, less than half of patients with locally advanced cervical cancer receive SOC treatment.

New Recommendations for Secondary Prevention of Cervical Cancer

New Recommendations for Secondary Prevention of Cervical Cancer

HPV DNA testing recommended in all resource settings; HIV should undergo screening more often

Low Incidence of Cervical Cancer for HPV-Negative Women

Low Incidence of Cervical Cancer for HPV-Negative Women

Human papillomavirus (HPV)-negative women have low long-term incidence of cervical cancer and CIN3+, which supports an extension of the cervical screening interval beyond five years for some, according to a study.

Additional Evidence HPV Vaccine Protects Against Cervical Cancer

Additional Evidence HPV Vaccine Protects Against Cervical Cancer

The vaccine against human papillomavirus (HPV) infection appears even more effective than previously believed and protection appears to occur even when only one or two of the recommended doses are given.

HIV Infection Worsens Survival of Patients With Cervical Cancer

HIV Infection Worsens Survival of Patients With Cervical Cancer

By

HIV is associated with reduced cancer-specific survival among women with invasive cervical cancer.

Routine Pap Smears Improve Cervical Cancer Risk in Women Older Than 65 Years

By

Despite confirmation of a link between routine Pap smear screening and a lower risk of developing cervical cancer in women older than 65 years, most US health guidelines discourage older women from undergoing routine Pap smears unless they have pre-existing risk factors.

HPV Vaccination Program Reduces Cervical Cell Anomalies in Young Women

HPV Vaccination Program Reduces Cervical Cell Anomalies in Young Women

By

Fewer cervical cell anomalies were present on cervical cancer screens of young women in Canada who received the HPV vaccine through a school-based program.

CDC: Most HPV-Linked Cancers Are Preventable

CDC: Most HPV-Linked Cancers Are Preventable

Cervical cancer, and oropharyngeal cancers in men, account for most HPV-associated cancers.

Patient Navigation Significantly Improves Cancer Screening Rates

Patient Navigation Significantly Improves Cancer Screening Rates

By

The addition of a patient navigation component to a population-based IT system boosted screening rates for breast cancer, cervical cancer, and colorectal cancer in patients at high risk for nonadherence.

ASCO Releases Resource-Stratified Guidelines for Management of Invasive Cervical Cancer

ASCO Releases Resource-Stratified Guidelines for Management of Invasive Cervical Cancer

By

ASCO has published its first clinical practice guideline on invasive cervical cancer, and the guidelines are the first to offer treatment recommendations tailored to resource availability.

Protein Identified That Could Prevent Tumor Growth in Cervical Cancer

By

A protein has been identified that can inhibit cellular inflammation, a major contributor to the growth of cervical cancer.

ASCO Develops Care Recommendations for Invasive Cervical Cancer

ASCO Develops Care Recommendations for Invasive Cervical Cancer

The American Society for Clinical Oncology has developed guidelines for the management and palliative care of women diagnosed with invasive cervical cancer.

More Than HPV Vaccine Uptake Is Needed to Reduce the Burden of HPV-associated Cancers

More Than HPV Vaccine Uptake Is Needed to Reduce the Burden of HPV-associated Cancers

By

Although HPV vaccination is expected to decrease the cancer burden from HPV across all racial and ethnic groups, some disparities are expected to persist and widen if their causes are not addressed, including lack of access to screening, timely diagnoses, and treatment.

Chronic HBV Treatment Linked to Increased Rates of Colorectal and Cervical Cancer

Chronic HBV Treatment Linked to Increased Rates of Colorectal and Cervical Cancer

By

A potential link between long-term oral treatment with nucleos(t)ide analogues for chronic hepatitis B virus (HBV) and an increased risk of colorectal and cervical cancers was demonstrated.

Nuclear Imaging Offers Noninvasive Assessment of Early Stage Cervical Cancer

By

In patients with cervical cancer who do not have enlarged lymph nodes, SPECT-MRI imaging of their sentinel lymph nodes (SLNs) could assess whether metastases are present.

Adherence to Pap Smear Testing Not Influenced by Free or For-a-fee Among Low-income Swedish Women

By

Offering free pap smears for cervical cancer screening did not increase pap smear frequency in low income women, even though low income and socioeconomic status are more likely to predict women skipping pap smears.

Follow-up of Screening Results Varies Between Breast, Cervical, and Colorectal Cancers

By

Follow-up of people whose screening examinations showed abnormal findings occurred faster for breast cancer than for colorectal and cervical cancers, according to a recent study involving more than 1 million people who underwent screening for these cancers.

Obesity Is Not a Factor in Racial or Ethnic Disparities in Cancer Screening Adherence

By

Adherence to cancer screening recommendations was not found to vary by race/ethnicity and body weight/obesity. In a focused look at the influence of body mass index (BMI) as a measure of obesity, some screening disparities may be decreasing.

Incidence of Undetected Cancer in Patients Undergoing Gynecologic Surgery for a Benign Condition Higher Than Estimated

By

Researchers in Massachusetts sought to determine how frequently cancer is diagnosed in women after undergoing gynecologic surgery for a problem believed to be benign.

Affordable Care Act (ACA) Impacts Stage at Diagnosis and Fertility-Sparing Treatment in Young Women With Cervical Cancer

Affordable Care Act (ACA) Impacts Stage at Diagnosis and Fertility-Sparing Treatment in Young Women With Cervical Cancer

By

Both the stage of cervical cancer at diagnosis and the receipt of fertility-sparing treatment among young women age 21 to 25 years, but not among women age 26 to 34 years, is associated with the Affordable Care Act Dependent Coverage Expansion provision.

Clinical Trial Shows Vaccine Clears Some Precancerous Cervical Lesions

Clinical Trial Shows Vaccine Clears Some Precancerous Cervical Lesions

By

Scientists used a genetically engineered vaccine to successfully eradicate high-grade precancerous cervical lesions in nearly one-half of women who received the vaccine in a clinical trial.

Health Care Barriers Contribute to Delays in Follow-Up Screening for Women With Cancer

Health Care Barriers Contribute to Delays in Follow-Up Screening for Women With Cancer

A better understanding of the association between barriers to care and clinical outcomes within patient navigation programs.

Patient Navigators Improve Cervical Cancer Screening Follow-Up

Patient Navigators Improve Cervical Cancer Screening Follow-Up

By

A patient navigator program was successful in lowering the rate of missed appointments for cervical cancer evaluation following a Pap smear by twenty percent.

Extended-Field IMRT Does Not Increase Risk of Duodenal Toxicity

By

Women with cervical or endometrial cancer can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal toxicity.

Fatalism May Encourage Avoidance of HPV Vaccination

By

Fatalistic beliefs may affect completion of the human papillomavirus (HPV) vaccine series in some areas of the United States.

High-grade cervical lesions declining in young women

By

A decrease in cervical lesions among young women in the United States has been observed, but the cause for this drop is not proven.

Incidence of precancerous cervical lesions decreasing among young women

Incidence of precancerous cervical lesions decreasing among young women

Incidence of high-grade cervical lesions in young women has significantly decreased, but the declines were likely due to reduced screening.

HPV vaccine may be effective with just one dose, not three

HPV vaccine may be effective with just one dose, not three

One dose of the HPV vaccine may be sufficient to protect girls from cervical cancer rather than the currently recommended three doses.

Inconsistent Medicaid expansion would widen disparities in screenings for women's cancers

By

Low-income and women without insurance in states that are not expanding their Affordable Care Act (ACA) Medicaid coverage are less likely to receive breast and cervical cancer screenings.

Combined brachytherapy techniques should be benchmark for cervical cancer treatment

An investigation on the late side effects of a combination of two forms of brachytherapy to treat cervical cancer has revealed that the technique delivers higher radiation doses to the tumor without additional treatment-related complications afterwards.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs